The CDCN made its mark at the American Society of Hematology’s Annual Meeting and Exposition (ASH), the premier conference of the global hematology-oncology community. The ASH annual meeting was an incredible opportunity to bring together the CDCN’s global network of physicians and researchers to inform the wider hematology community about cutting-edge Castleman disease research.
CDCN Annual Working Dinner
The CDCN held its annual ASH Working Dinner which was attended by over 70 leading Castleman disease physicians and researchers from around the world. The dinner served as an opportunity to review new research, ask and answer questions, and discuss ways to improve Castleman disease patient care. Learn more about the meeting here!
Ruth-Anne Langan Pai wins ASH Abstract Award
Ruth-Anne Langan Pai, an immunology PhD student at the University of Pennsylvania who has dedicated her research and thesis to Castleman disease, won a prestigious 2019 ASH Abstract Achievement Award. Her presented work involves phenotypic and transcriptional profiling of immune cells in idiopathic multicentric Castleman disease and is currently under external review for publication! Learn more about her work (labeled Multiomic Profiling of iMCD-TAFRO) and the work of all CDCN-supported research projects on our Research Pipeline.
Three CDCN posters on Castleman disease at ASH 2019
The CDCN is proud to highlight the work of Sheila Pierson and Ruth-Anne Langan Pai, who presented three abstracts at ASH! Click on the links to learn more and read their research abstracts.
- “Quantitative Changes in Serum Proteins Including CXCL13 Are Early Indicators of Response to Anti-IL6 Therapy in Idiopathic Multicentric Castleman Disease” (Session 203, Abstract# 3599, Orange County Convention Center, Hall B)
- “Type I Interferon Response Identified through Phenotypic and Transcriptional Profiling of Circulating Immune Cells during Idiopathic Multicentric Castleman Disease Flare” (Session 203, Abstract#1046, Orange County Convention Center, Hall B)
- “Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients Remain” (Session 623, Abstract#1540, Orange County Convention Center, Hall B)
CDCN Virtual Posters
Check out other Castleman disease-related posters that were presented at ASH this year!